Comparative clinical study on Buras and Rohitaka in Liver Disorder
Phase 2
- Conditions
- Health Condition 1: null- Elevated AST and ALT more than 40 IU/L levels measured at screening
- Registration Number
- CTRI/2017/11/010371
- Lead Sponsor
- ational Institute of Ayurveda Jaipur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Elevated AST and ALT More than 40 IU/l measured at screening in the study laboratory
3. Readiness to comply with Randomization , treatment and follow up
4. Subject giving written informed consent
Exclusion Criteria
1. Patient with hepatocellular carcinoma, cirrhosis, fulminant hepatitis.
2. Any other serious disease limiting life expectancy
3. Pregnancy and Lactation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To Study the efficacy of Rhododendron arboreum and Tecomela undulata wsr to their hepatoprotective action in clinical trialTimepoint: After three months providing the test drugs, count from the day of first dose administration.
- Secondary Outcome Measures
Name Time Method To compare the hepatoprotective action of Rhododendron arboreum and Tecomela undulata in atients of liver diseaseTimepoint: 18 months